抗凝固拮抗薬の世界市場2020-2026:薬物クラス別(プロトロンビン複合体濃縮物、凝固因子、モノクローナル抗体、フィトナジオン、その他)、地域別

◆英語タイトル:Global Anticoagulant Reversal Drugs Market Size study, by Drug Class (Prothrombin Complex Concentrates, Coagulation Factors, Monoclonal Antibodies, Phytonadione and Others), and Regional Forecasts 2020-2026
◆商品コード:BZW20JN001
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2020年4月10日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥514,800見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥650,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、抗凝固拮抗薬の世界市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、薬物クラス別(プロトロンビン複合体濃縮物、凝固因子、モノクローナル抗体、フィトナジオン、その他)分析、地域別分析、競争状況などを含め、次の構成でお届け致します。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・抗凝固拮抗薬の世界市場:薬物クラス別(プロトロンビン複合体濃縮物、凝固因子、モノクローナル抗体、フィトナジオン、その他)
・抗凝固拮抗薬の世界市場:地域別
・競争状況
【レポートの概要】

Global Anticoagulant Reversal Drugs Market is valued approximately at USD 811.56 Million in 2019 and is anticipated to grow with a healthy growth rate of more than 15.6% over the forecast period 2019-2026. Anticoagulant drugs are medicines that has application in protection from blood clotting, used to reverse or balance bleeding. It is also helpful in prevention of risk related to the anticoagulants that arises due to the overdose of an anticoagulant therapy or unplanned surgery. It also prevents from serious conditions such as strokes and heart attacks to the individual suffering from blood clots. The anticoagulant reversal drugs have commendable application in treatment and diagnosis of cardiovascular disease due to its advent benefits of removing and dissolving blood clots. Therefore, increasing prevalence of cardiovascular disease across the globe is attributed to the growth of market over the forecast years. For instance: As per the World Health Organization, Cardiovascular diseases are estimated as the primary reason of death due to disease across the globe which accounts for over 17.9 million, 31% of worldwide death each year due to cardiovascular disease. It is estimated that more than 75% of deaths occurred through cardiovascular disease is emerged in low and middle-income countries and over 85% of deaths are taking place due to sever heart attacks and strokes. Moreover, rise in geriatric population and rapid growth of problems regarding blood clots in such population gave exponential rise in the demand of anticoagulant reversal drugs across the globe. However, the high cost of patented drugs would deter the growth of market in the emerging economies over the forecast years.

The regional analysis of global Anticoagulant Reversal Drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rapid growth in cases of cardiovascular disease in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026. Factors such as presence of large geriatric population in the emerging economies of the region would create lucrative growth prospects for the Anticoagulant Reversal Drugs market across Asia-Pacific region.

Major market player included in this report are:
Portola Pharmaceuticals Inc
Boehringer Ingelheim GmbH
CSL Behring Limited
Pfizer Inc
Octapharma AG
Bausch Health Companies Inc
Amneal Pharmaceuticals Inc
Fresenius Kabi AG
Perosphere Pharmaceuticals Inc

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Class:
Prothrombin Complex Concentrates
Coagulation Factors
Monoclonal Antibodies
Phytonadione
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018
Base year – 2019
Forecast period – 2020 to 2026

Target Audience of the Global Anticoagulant Reversal Drugs Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Million)
1.2.1. Anticoagulant Reversal Drugs Market, by Region, 2018-2026 (USD Million)
1.2.2. Anticoagulant Reversal Drugs Market, by Drug Class, 2018-2026 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Anticoagulant Reversal Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Anticoagulant Reversal Drugs Market Dynamics
3.1. Anticoagulant Reversal Drugs Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Anticoagulant Reversal Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Anticoagulant Reversal Drugs Market, by Drug Class
5.1. Market Snapshot
5.2. Global Anticoagulant Reversal Drugs Market by Drug Class, Performance – Potential Analysis
5.3. Global Anticoagulant Reversal Drugs Market Estimates & Forecasts by Drug Class 2016-2026 (USD Million)
5.4. Anticoagulant Reversal Drugs Market, Sub Segment Analysis
5.4.1. Prothrombin Complex Concentrates
5.4.2. Coagulation Factors
5.4.3. Monoclonal Antibodies
5.4.4. Phytonadione
5.4.5. Others
Chapter 6. Global Anticoagulant Reversal Drugs Market, Regional Analysis
6.1. Anticoagulant Reversal Drugs Market, Regional Market Snapshot
6.2. North America Anticoagulant Reversal Drugs Market
6.2.1. U.S. Anticoagulant Reversal Drugs Market
6.2.1.1. Drug Class breakdown estimates & forecasts, 2016-2026
6.2.2. Canada Anticoagulant Reversal Drugs Market
6.3. Europe Anticoagulant Reversal Drugs Market Snapshot
6.3.1. U.K. Anticoagulant Reversal Drugs Market
6.3.2. Germany Anticoagulant Reversal Drugs Market
6.3.3. Rest of Europe Anticoagulant Reversal Drugs Market
6.4. Asia-Pacific Anticoagulant Reversal Drugs Market Snapshot
6.4.1. China Anticoagulant Reversal Drugs Market
6.4.2. India Anticoagulant Reversal Drugs Market
6.4.3. Japan Anticoagulant Reversal Drugs Market
6.4.4. Rest of Asia Pacific Anticoagulant Reversal Drugs Market
6.5. Latin America Anticoagulant Reversal Drugs Market Snapshot
6.5.1. Brazil Anticoagulant Reversal Drugs Market
6.5.2. Mexico Anticoagulant Reversal Drugs Market
6.6. Rest of The World Anticoagulant Reversal Drugs Market

Chapter 7. Competitive Intelligence
7.1. Top Market Strategies
7.2. Company Profiles
7.2.1. Portola Pharmaceuticals, Inc.
7.2.1.1. Key Information
7.2.1.2. Overview
7.2.1.3. Financial (Subject to Data Availability)
7.2.1.4. Product Summary
7.2.1.5. Recent Developments
7.2.2. Boehringer Ingelheim GmbH
7.2.3. CSL Behring Limited
7.2.4. Pfizer Inc
7.2.5. Octapharma AG
7.2.6. Bausch Health Companies, Inc.
7.2.7. Amneal Pharmaceuticals Inc
7.2.8. Fresenius Kabi AG
7.2.9. Perosphere Pharmaceuticals Inc
Chapter 8. Research Process
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes
8.3. Research Assumption

List of Tables
TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET
TABLE 3. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD MILLION)
TABLE 7. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY DRUG CLASS 2016-2026 (USD MILLION)
TABLE 8. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 9. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 10. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 11. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 12. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 13. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 14. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 15. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 16. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 17. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 18. U.S. ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 19. U.S. ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 20. U.S. ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 21. CANADA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 22. CANADA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 23. CANADA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 24. UK ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 25. UK ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 26. UK ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 27. GERMANY ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 28. GERMANY ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 29. GERMANY ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 30. ROE ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 31. ROE ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 32. ROE ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 33. CHINA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 34. CHINA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 35. CHINA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 36. INDIA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 37. INDIA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 38. INDIA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 39. JAPAN ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 40. JAPAN ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 41. JAPAN ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 42. ROAPAC ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 43. ROAPAC ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 44. ROAPAC ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 45. BRAZIL ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 46. BRAZIL ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 47. BRAZIL ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 48. MEXICO ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 49. MEXICO ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 50. MEXICO ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 51. ROLA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 52. ROLA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 53. ROLA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 54. ROW ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 55. ROW ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 56. ROW ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[抗凝固拮抗薬の世界市場2020-2026:薬物クラス別(プロトロンビン複合体濃縮物、凝固因子、モノクローナル抗体、フィトナジオン、その他)、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆